SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-026050
Filing Date
2021-07-29
Accepted
2021-07-29 16:18:37
Documents
14
Period of Report
2021-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20000149x1_8k.htm   iXBRL 8-K 34678
2 EXHIBIT 99.1 ny20000149x1_ex99-1.htm EX-99.1 13585
6 ny20000149x1_ex99-1img01.jpg GRAPHIC 4665
  Complete submission text file 0001140361-21-026050.txt   197070

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210729.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210729_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210729_pre.xml EX-101.PRE 16038
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20000149x1_8k_htm.xml XML 4227
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 211127694
SIC: 2833 Medicinal Chemicals & Botanical Products